salmonella VNP20009
Term · Oncology and biomedicine · MLC-T-ONC-016626
A genetically stable Salmonella typhimurium strain, attenuated by chromosomal deletion of the purI and msbB genes, with tumor-targeting activity. In rodent models, salmonella VNP20009 has been shown to selectively accumulate and grow in a variety of tumor types, inhibiting the growth of primary and metastatic tumors. This agent may be genetically engineered to contain transgenes that express therapeutic agents or cell surface tumor-associated antigen-specific antibodies, such as CEA-specific antibodies, which may improve its tumor targeting and therapeutic potential.
| Identifier | MLC-T-ONC-016626 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | auxotrophic lipid A S. typhimurium mutant; live, attenuated Salmonella typhimurium |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-016626",
"term": "salmonella VNP20009",
"field": "Oncology and biomedicine",
"definition": "A genetically stable Salmonella typhimurium strain, attenuated by chromosomal deletion of the purI and msbB genes, with tumor-targeting activity. In rodent models, salmonella VNP20009 has been shown to selectively accumulate and grow in a variety of tumor types, inhibiting the growth of primary and metastatic tumors. This agent may be genetically engineered to contain transgenes that express therapeutic agents or cell surface tumor-associated antigen-specific antibodies, such as CEA-specific antibodies, which may improve its tumor targeting and therapeutic potential.",
"synonyms": [
"auxotrophic lipid A S. typhimurium mutant",
"live, attenuated Salmonella typhimurium"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/salmonella-vnp20009/"
}
Record 14,656 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.